Buscar
Mostrando ítems 31-40 de 273
Diagnosis of 5α-reductase type 2 deficiency: Contribution of anti-Müllerian hormone evaluation
(2005-12-01)
Aim: To evaluate anti-Müllerian hormone (AMH) levels in patients with clinical and molecular diagnosis of 5α-reductase 2 deficiency. Patients and methods: Data from 14 patients whose age ranged from 21 days to 29 years ...
Diagnosis of 5α-reductase type 2 deficiency: Contribution of anti-Müllerian hormone evaluation
(2005-12-01)
Aim: To evaluate anti-Müllerian hormone (AMH) levels in patients with clinical and molecular diagnosis of 5α-reductase 2 deficiency. Patients and methods: Data from 14 patients whose age ranged from 21 days to 29 years ...
Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating a-asarone-based HMG-CoA reductase inhibitors
(2012-11-28)
A series of a-asarone-based analogues was designed by conducting docking experiments with published
crystal structures of human HMG-CoA reductase. Indeed, synthesis and evaluation of this series showed a
highly ...
Defici??ncia de 5??-redutase tipo 2: revis??o de literatura.
(Faculdade de Medicina da BahiaFMBbrasil, 2016-09-02)
Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology
(Wiley-blackwellMaldenEUA, 2010)